KMCH Share Price: Q3 mein Profit ka Dhamaka! **12.5%** growth, Investors khush!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAnanya Iyer|Published at:
KMCH Share Price: Q3 mein Profit ka Dhamaka! **12.5%** growth, Investors khush!
Overview

Arre yaar, Kovai Medical Center (KMCH) ne Q3 FY26 mein kamaal ka performance dikhaya hai! Company ka revenue **14.65%** badh gaya hai year-on-year aur profit mein bhi **12.5%** ka tagda jump aaya hai.

Aakhir kya hai KMCH ke Results mein?

Chalo, details mein dekhte hain. Kovai Medical Center and Hospital Limited ne Q3 FY26 mein financial performance ko super strong banaya hai. Unka Revenue from Operations 14.65% badh kar ₹40,661.98 lakhs ho gaya, jo pichhle saal issi quarter mein ₹35,469.58 lakhs tha. EBITDA bhi 15.03% upar gaya, pahunch gaya ₹11,473.74 lakhs pe. Sabse important, Profit After Tax (PAT) 12.48% badh kar ₹6,501.99 lakhs ho gaya hai. Aur haan, Earnings Per Share (EPS) bhi 12.47% badh kar ₹59.42 ho gaya.

Agar pichhle quarter se compare karein, toh revenue mein 4.07% ka increase dikha aur PAT toh 10.46% badh gaya, yaani ₹5,886.14 lakhs se ₹6,501.99 lakhs ho gaya.

Aur agar poore 9 mahine (9MFY26) ka figure dekho, toh revenue 15.58% badha hai, ₹1,17,095.23 lakhs tak pahunch gaya. Profit (PAT) toh 17.41% tez hua hai, ₹18,110.68 lakhs pe. EPS bhi 17.41% badh kar ₹165.51 ho gaya hai.

Margins aur Labour Codes ka kya scene hai?

Sabse acchi baat ye hai ki company ne apne EBITDA margins ko stable rakha hai, 28.22% pe, jo pichhle saal 28.12% tha. Iska matlab hai ki cost management acche se ho rahi hai. Aur woh jo naye Labour Codes aa rahe hain, unka koi bada impact company par nahi padega, management ne yeh confirm kar diya hai.

Aage kya expect karein?

Abhi management ne future ke liye koi khaas guidance ya outlook nahi diya hai earnings call mein. Toh investors ko thoda market trends aur competitor performance par nazar rakhni hogi. Company patient volumes, occupancy rates aur future expansion plans par kaise perform karti hai, yeh dekhna important hoga.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.